DLA Piper advises Dechra Pharmaceuticals on acquisition of AST Farma and Le Vet
DLA Piper has advised Dechra Pharmaceuticals PLC on the acquisition of AST Farma and Le Vet in the Netherlands for a total consideration of €340 million and an associated £100m placing to raise funds for the transaction.